J.P. Morgan has published a research report on Medtronic MDT.
In the report, J.P. Morgan wrote, "Medtronic reported largely in-line 1Q results this morning. Revenues of $4.049B grew 7.3% reported (+2.4% constant currency; +1.1% organic) and came in $70M above consensus and $15M below our estimate."
J.P. Morgan rated Medtronic a Neutral with no price target given. Medtronic closed Monday at $31.18.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in